Symbio
San Diego, United States· Est. 2015
As your specialty CRO, Symbio has extensive experience supporting Phase I–IV drug development and medical device studies in dermatology and adjacent therapeutic areas.
Private Company
Funding information not available
About
As your specialty CRO, Symbio has extensive experience supporting Phase I–IV drug development and medical device studies in dermatology and adjacent therapeutic areas.
DiagnosticsMicrobiome